4//SEC Filing
Driscoll Martin J 4
Accession 0001209191-17-052800
CIK 0001566373other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:03 PM ET
Size
4.5 KB
Accession
0001209191-17-052800
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2017-09-14$14.84/sh+1,000$14,840→ 55,400 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001339402
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:03 PM ET
- Size
- 4.5 KB